Logo Logo

  • Home
  • Financial Assistance
  • GIST Summits
  • Contact Us
  • 215-340-9374
Menu
  • About GIST
    • What is GIST?
    • For New GIST Patients
      • Newbie Orientation
      • What to Ask Your Doctor
      • Diagnosing GIST
      • Monitoring Tests
    • SDH-deficient GIST
  • Treatments for GIST
    • Clinical Trials
      • Clinical Trials for GIST Cancer
    • GIST Treatment Guidelines
    • Surgery for GIST
    • Interventional Radiology
    • Off-Label Use of FDA-Approved Drugs
  • Resources & Links
    • Best Links
    • Links for Young Patients
    • Books about GIST
    • GIST Publications
    • CancerCare Booklet on GIST
  • Ask the Professional
    • Gleevec
      • Gleevec questions
      • Gleevec Side Effects and Tips
      • Pregnancy and Gleevec
    • Sutent
      • Sunitinib (Sutent) Experience in Use
    • Nutrition and GI Issues After GIST Surgery
  • About GSI
    • Organization
    • Donate
    • Voices of GIST
      • Video Galleries
    • Stories of Strength
    • GSI Community
      • Join our GIST Community
      • GIST Listserv
    • GSI Summits
      • GISTS 2017 Meeting
      • GISTS 2018 Meeting
      • GISTS 2019 Meeting

Crenolanib ARO-02 Trial Results

    Home > Treatments > Clinical Trials > Crenolanib ARO-02 Trial Results

 

  • Crenolanib trial
  • Navigator Trial (Avapritinib) results

We comply with the HONcode standard for trustworthy health information: verify here.

GIST on Facebook

Join us on Facebook

Contact Us

GIST Support International
12 Bomaca Drive
Doylestown,PA 18901

215- 340-9374
gsi@gistsupport.org

Copyright © 2006-2020 GIST Support International.

  • View Disclaimer
PHP Code Snippets Powered By : XYZScripts.com